Atlas Trials

GTN Therapy on Biomarkers of Immune Escape in Men With Biochemical Recurrence of Prostate Cancer After Primary Therapy

Clinical trial NCT01704274 · COMPLETED

Trial details

NCT number
NCT01704274
Sponsor
Dr. D. Robert Siemens
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2012-04-01
Primary completion
2017-01-01
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.